Icrucumab

Icrucumab
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76866-1mg 1 mg

7 - 10 business days*

220.00€
TGM-T76866-5mg 5 mg

7 - 10 business days*

637.00€
TGM-T76866-10mg 10 mg

7 - 10 business days*

970.00€
 
Description: Icrucumab ( IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular... more
Product information "Icrucumab"
Description: Icrucumab ( IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer. Target: VEGFR. References: LoRusso PM, et al. Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. Invest New Drugs. 2014 Apr,32(2):303-11.
Keywords: LY 3012212, IMC-18F1
Supplier: TargetMol
Supplier-Nr: T76866

Properties

Conjugate: No

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Icrucumab"
Write a review
or to review a product.
Viewed